PT-141 (10mg)
PT-141 is a melanocortin receptor agonist studied for sexual-function signaling pathways. In plain terms, it’s discussed as a peptide that acts on brain…
Mechanism of Action
See published literature and COA for batch-specific analytical data. Research use only — not for human or veterinary administration.
Research Applications
- In vitro laboratory research
- Receptor and pathway assays
- Comparative peptide studies
Specifications
| appearance | See COA for lot-specific appearance and identity confirmation |
Reconstitution (Laboratory)
Reconstitute with bacteriostatic water under sterile laboratory conditions unless otherwise specified for your protocol.
Storage & Handling
Lyophilized: 2–8 °C long-term. Reconstituted: refrigerate at 2–8 °C. Protect from light.
Quality Assurance
Every lot undergoes independent third-party HPLC purity analysis, mass spectrometry identity confirmation, and endotoxin testing (<0.5 EU/mg). Certificate of Analysis (COA) is stored against the SKU lot number and available through your research account portal.
Sources & References
- 1.Kingsberg SA, et al. Bremelanotide for the Treatment of Hypoactive Sexual Desire Disorder: Two Randomized Phase 3 Trials. Obstet Gynecol. 2019. · PubMed →
- 2.Simon JA, et al. Long-Term Safety and Efficacy of Bremelanotide for Hypoactive Sexual Desire Disorder. Obstet Gynecol. 2019. · PubMed →
- 3.Edinoff AN, et al. Bremelanotide for Treatment of Female Hypoactive Sexual Desire. Neurol Int. 2022. · PubMed →